Scale Music City Symposium

The Symposium for Cosmetic Advances and Laser Education (SCALE) is the premier multidisciplinary meeting for aesthetic medicine, surgery, and dermatology in the United States.


SCALE is an annual educational conference that provides evidence-based medicine, research, and current technologies in treating medical conditions as well as cosmetic concerns with current available products and technologies. The symposium offers an exciting and high-energy learning environment where attendees can receive tangible learning through live demonstrations on various procedures and treatments in both medical and cosmetic dermatology. The conference offers 30+ hours of CME/CE credit and attracts over 1,000 attendees.

Connect with us:

Latest from Scale Music City Symposium

Combination Approaches Drive Cosmeceutical Regimens

November 15, 2021

Article

Natural skincare ingredients are always trending, said Patricia K. Farris, MD, hear what she had to say about using these in combination with other regimens.

Game-Changers Advance Hair Loss Treatment

August 31, 2021

Article

More options are available to address alopecia, but not all are backed by equally solid science. Strategies for choosing and using new treatments and procedures for full-cycle hair loss management were highlighted at the Music City Symposium for Cosmetic Advances & Laser Education 16th Annual Meeting.

Preventing Keloid Recurrence With SRT

August 27, 2021

Article

Part 2 of Dermatology Times®’ coverage of a strategic look at superficial radiation therapy (SRT) presented at the recent Music City SCALE Symposium for Cosmetic Advances & Laser Education 16th Annual Meeting details this therapy’s potential for reducing keloid recurrence.

SRT Shows Positive Outcomes for NMSC

August 25, 2021

Article

Part 1 of Dermatology Times®’ coverage of a strategic look at superficial radiation therapy (SRT) presented at the recent Music City SCALE Symposium for Cosmetic Advances & Laser Education 16th Annual Meeting in Nashville, Tennessee, showcases this therapy’s efficacy in treating keratinocytic skin cancers.